Table 2.
Characteristics of patients included in meta-analysis. Values are numbers (percentages) unless indicated otherwise
| Characteristics | Training (n=395) | Control (n=406) |
|---|---|---|
| Male | 88.4 | 87.2 |
| Mean (SD) age (years) | 60.5 (9.3) | 59.7 (13.2) |
| Mean (SD) NYHA class | 2.6 (0.6) | 2.5 (0.6) |
| Ischaemic heart disease | 59.7 | 58.7 |
| Mean (SD) left ventricular ejection fraction (%) | 27.9 (8.3) | 27.0 (8.6) |
| Mean (SD) peak oxygen uptake (ml/kg/min) | 15.4 (4.0) | 15.2 (3.9) |
| Mean (SD) renal function (laboratory findings)*: | ||
| Serum creatinine (mg/dL) | 1.4 (0.4) | 1.4 (0.5) |
| Urea (mg/dL) | 61.3 (40) | 63.7 (38) |
| Drugs†: | ||
| Angiotensin converting enzyme inhibitors | 73.4 | 73.2 |
| Anticoagulant | 40.0 | 36.9 |
| Aspirin | 30.1 | 30.8 |
| Amiodarone | 10.9 | 12.8 |
| β adrenergic blockade | 12.2 | 14.5 |
| Digitalis | 50.4 | 47.8 |
| Diuretics | 68.9 | 69.5 |
| Nitrate | 40.0 | 31.0 |
NYHA=New York Heart Association.
*
Renal function known for 146 patients.
†
Drugs known for 655 patients.